Collection of documents related to the status of the clinical trial
(öffnet in neuem Fenster)
Study initiation package
(öffnet in neuem Fenster)
Study initiation package including: •Registration number of the clinical study in a registry meeting WHO Registry criteria •Final version of study protocol as approved by the regulator(s) / ethics committee(s)•Regulatory and ethics (if applicable, institutional) approvals required for the enrolment of the first study participant
Report on the status of posting results for the screening people with DM for TB
(öffnet in neuem Fenster)
Summary results posted in the applicable registry/ies
Population impact
(öffnet in neuem Fenster)
Population Impact of LTBI screening for DM
Midterm recruitment report
(öffnet in neuem Fenster)
The report includes an overview of the number of recruited participants by clinical sites, any problems in recruitment and, if applicable, a detailed description of implemented and planned measures to compensate for any incurred delays.
Annual consortium meetings 1
(öffnet in neuem Fenster)
Plan and hold annual consortium meeting
Performance of CAD4TB system
(öffnet in neuem Fenster)
Evaluation of use of the CAD4TB system for active TB screening
Data sharing policy
(öffnet in neuem Fenster)
Updated Data sharing policy, which will be updated continuously
Plan for dissemination and exploitation, including publication policy
(öffnet in neuem Fenster)
Updated plan for dissemination and exploitation including communication activities
TB, HIV and LTBI prevalence in DM
(öffnet in neuem Fenster)
Prevalence of LTBI, and TB and HIV disease among people with DM